- Open Access
Correction to: Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents Iris
Journal of Nanobiotechnology volume 20, Article number: 229 (2022)
Correction to: Journal of Nanobiotechnology (2022) 20:64 https://doi.org/10.1186/s12951-022-01272-5
Following publication of the original article , the authors identified an error in Fig. 1 and Fig. 4. The correct figures are given in this correction article.
The error was in the “R-groups” (R1 and R2) of the molecules IH18 and IH20 in Fig. 1b and in Additional file 1: Figure S1. R1 and R2 were accidently swapped. In Fig. 4d the error was in the depiction of the tumor/blood ratio. During transfer of the data to this bar graph the data got unintentionally transformed.
Hagemans M, Wierstra PJ, Steuten K, MolkenboerKuenen JDM, Dalen D, Beest M, Schoot JMS, Ilina O, Gotthardt M, Figdor CG, Scheeren FA, Heskamp S, Verdoes M. Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defned imaging agents Iris. J Nanobiotechnol. 2022;20:64. https://doi.org/10.1186/s12951-022-01272-5.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original article has been revised.
About this article
Cite this article
Hagemans, I.M., Wierstra, P.J., Steuten, K. et al. Correction to: Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents Iris. J Nanobiotechnol 20, 229 (2022). https://doi.org/10.1186/s12951-022-01306-y